WARQUIGNIESPHARMA
0835.684.001 · rovalta.com · 23/09/2026
ACTIVE
WARQUIGNIESPHARMA
Financial year 2025 · closed on 31/12/2025
Net result
45,2 k €
-24.1% YoY
Gross margin
140 k €
-10.0% YoY
Equity
213 k €
+26.9% YoY
Overview
What does WARQUIGNIESPHARMA do?
WARQUIGNIESPHARMA is a Private limited company incorporated in 2011. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Colfontaine.
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0835.684.001
Incorporation
20/04/2011
Legal form
Private limited company
Registered office
Pavé de Warquignies 108
7340 Colfontaine · WallonieSee on map
7340 Colfontaine · WallonieSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Activities (NACE)
Joint committees (1)
- 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 14 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||
| Gross margin | 140 k € | -10.0% | 155,6 k € | +8.0% | 144 k € | -2.3% | 147,3 k € | +7.9% | 136,5 k € | -7.2% | 147 k € | +16.5% | 126,2 k € | -7.3% | 136,2 k € | +0.8% | 135,1 k € | -7.6% | 146,3 k € | -4.2% | 152,7 k € | -2.1% | 156 k € | +11.6% | 139,8 k € | -19.6% | 174 k € |
| EBITDA | 97,5 k € | -14.3% | 113,9 k € | +11.7% | 101,9 k € | -3.2% | 105,3 k € | +4.5% | 100,8 k € | -8.5% | 110,2 k € | +19.4% | 92,3 k € | +12.1% | 82,3 k € | +3.2% | 79,8 k € | -11.6% | 90,3 k € | -7.7% | 97,9 k € | -16.1% | 116,6 k € | +12.1% | 104 k € | -18.0% | 126,8 k € |
| Operating result | 71,9 k € | -17.0% | 86,6 k € | +17.4% | 73,8 k € | +29.9% | 56,8 k € | +3.5% | 54,9 k € | -15.9% | 65,3 k € | +80.2% | 36,2 k € | +225% | 11,2 k € | +285% | 2,9 k € | -58.4% | 7 k € | +23.6% | 5,6 k € | -77.0% | 24,4 k € | +84.9% | 13,2 k € | -56.2% | 30,2 k € |
| Net result | 45,2 k € | -24.1% | 59,6 k € | +23.0% | 48,4 k € | +48.4% | 32,6 k € | +2.8% | 31,7 k € | -34.6% | 48,5 k € | +166% | 18,2 k € | +325% | -8,1 k € | +58.3% | -19,4 k € | -12.6% | -17,3 k € | +14.7% | -20,2 k € | -473% | -3,5 k € | +74.9% | -14,1 k € | -94.5% | -7,2 k € |
| Balance sheet | |||||||||||||||||||||||||||
| Equity | 213 k € | +26.9% | 167,8 k € | +55.1% | 108,2 k € | +81.0% | 59,8 k € | +120% | 27,1 k € | +694% | -4,6 k € | +91.4% | -53 k € | +25.6% | -71,2 k € | -12.8% | -63,1 k € | -44.4% | -43,7 k € | -65.2% | -26,5 k € | -325% | -6,2 k € | -131% | -2,7 k € | -124% | 11,4 k € |
| Total assets | 299,7 k € | -7.4% | 323,7 k € | -3.5% | 335,5 k € | -17.7% | 407,6 k € | +3.2% | 394,8 k € | -5.3% | 417 k € | -2.4% | 427,3 k € | -9.8% | 473,5 k € | -13.2% | 545,4 k € | -14.4% | 636,8 k € | -5.7% | 675,6 k € | -9.5% | 746,2 k € | -11.0% | 838 k € | +28.5% | 652 k € |
| Cash | 138,1 k € | +4.2% | 132,6 k € | -2.3% | 135,7 k € | -27.2% | 186,3 k € | +20.7% | 154,3 k € | +6.1% | 145,4 k € | +20.9% | 120,2 k € | -0.2% | 120,5 k € | -17.9% | 146,8 k € | -1.8% | 149,4 k € | +41.2% | 105,8 k € | +47.3% | 71,8 k € | -27.1% | 98,4 k € | +8.8% | 90,5 k € |
| Debts | 86,7 k € | -44.4% | 156 k € | -31.4% | 227,3 k € | -34.6% | 347,8 k € | -5.4% | 367,7 k € | -12.8% | 421,6 k € | -12.2% | 480,3 k € | -11.8% | 544,7 k € | -10.5% | 608,5 k € | -10.6% | 680,5 k € | -3.1% | 702 k € | -6.7% | 752,5 k € | -10.5% | 840,7 k € | +31.2% | 640,7 k € |
| Other | |||||||||||||||||||||||||||
| Workforce | – | – | – | – | – | – | – | – | – | – | 1,4 ETP | – | 1,0 ETP | 0.0% | 1,0 ETP | ||||||||||||
Estimate
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 2 active · 6 ended
Active mandates
Marjorie Virginie HOUDART
ActivePaul Louis TASSIN
ActiveEnded mandates
Marjorie Virginie HOUDART
EndedPaul Louis TASSIN
EndedMarjorie HOUDART
EndedMarjorie HOUDART
EndedFinancials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/07/2026 | 16/10/2025 | 03/06/2024 | 22/09/2023 | 29/08/2022 | 19/07/2021 |
| General meeting | 30/06/2026 | 27/05/2025 | 28/05/2024 | 18/09/2023 | 24/05/2022 | 25/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
14 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 30/06/2026 | 31/07/2026 | French | |
| Abridged model | 31/12/2024 | 27/05/2025 | 16/10/2025 | French | |
| Abridged model | 31/12/2023 | 28/05/2024 | 03/06/2024 | French | |
| Abridged model | 31/12/2022 | 18/09/2023 | 22/09/2023 | French | |
| Abridged model | 31/12/2021 | 24/05/2022 | 29/08/2022 | French | |
| Abridged model | 31/12/2020 | 25/05/2021 | 19/07/2021 | French | |
| Abridged model | 31/12/2019 | 26/05/2020 | 25/08/2020 | French | |
| Abridged model | 31/12/2018 | 28/05/2019 | 27/08/2019 | French | |
| Micro model | 31/12/2017 | 22/05/2018 | 09/07/2018 | French | |
| Micro model | 31/12/2016 | 23/05/2017 | 25/07/2017 | French | |
| Abridged model | 31/12/2015 | 24/05/2016 | 01/07/2016 | French | |
| Abridged model | 31/12/2014 | 22/08/2015 | 27/08/2015 | French | |
| Abridged model | 31/12/2013 | 10/08/2014 | 27/08/2014 | French | |
| Abridged model | 31/12/2012 | 28/05/2013 | 05/07/2013 | French |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 2 active · 6 ended
Active mandates
Marjorie Virginie HOUDART
ActivePaul Louis TASSIN
ActiveEnded mandates
Marjorie Virginie HOUDART
EndedPaul Louis TASSIN
EndedMarjorie HOUDART
EndedMarjorie HOUDART
EndedShareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202545,2 k €↓
- 2024Annual accounts 202459,6 k €↑
- 2024Name changeWARQUIGNIESPHARMA
- 2023Annual accounts 202348,4 k €↑
- 2022Annual accounts 202232,6 k €↑
- 2021Annual accounts 202131,7 k €↓
- 2021Name changeWARQUIGNIES PHARMA
- 2020Annual accounts 202048,5 k €↑
- 2019Annual accounts 201918,2 k €↑
- 2018Annual accounts 2018-8,1 k €↑
- 2017Annual accounts 2017-19,4 k €↓
- 2016Annual accounts 2016-17,3 k €↑
- 2015Annual accounts 2015-20,2 k €↓
- 2014Annual accounts 2014-3,5 k €↑
- 2013Annual accounts 2013-14,1 k €↓
- 2012Annual accounts 2012-7,2 k €
- 20/04/2011IncorporationPrivate limited company